AU5491398A - Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints - Google Patents

Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints

Info

Publication number
AU5491398A
AU5491398A AU54913/98A AU5491398A AU5491398A AU 5491398 A AU5491398 A AU 5491398A AU 54913/98 A AU54913/98 A AU 54913/98A AU 5491398 A AU5491398 A AU 5491398A AU 5491398 A AU5491398 A AU 5491398A
Authority
AU
Australia
Prior art keywords
bone
palliation
diseases
composition
metal ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54913/98A
Inventor
Wei Jia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitreoak Ltd
Original Assignee
Mitreoak Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitreoak Ltd filed Critical Mitreoak Ltd
Publication of AU5491398A publication Critical patent/AU5491398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54913/98A 1997-01-07 1998-01-07 Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints Abandoned AU5491398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/779,719 US5902825A (en) 1997-01-07 1997-01-07 Composition and method for the palliation of pain associated with diseases of the bone and bone joints
US08779719 1997-01-07
PCT/GB1998/000037 WO1998030246A1 (en) 1997-01-07 1998-01-07 Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints

Publications (1)

Publication Number Publication Date
AU5491398A true AU5491398A (en) 1998-08-03

Family

ID=25117320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54913/98A Abandoned AU5491398A (en) 1997-01-07 1998-01-07 Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints

Country Status (4)

Country Link
US (1) US5902825A (en)
EP (1) EP0952854A2 (en)
AU (1) AU5491398A (en)
WO (1) WO1998030246A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794371B1 (en) * 1999-10-18 2004-09-21 The Dow Chemical Company Aminoalkylenephosphonates for treatment of bone disorders
EP1225903A2 (en) * 1999-10-18 2002-07-31 The Dow Chemical Company Aminoalkylenephosphonates for treatment of bone disorders
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
GB0015745D0 (en) 2000-06-27 2000-08-16 Shire Holdings Ag Treatment of bone diseases
NO313180B1 (en) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Visiting alpha particles emitting radiopharmaceuticals
AU2002214824B2 (en) * 2000-11-16 2007-06-28 Biotomo Pty Ltd Processes for treating coral and coating an object
DK1389102T3 (en) * 2001-04-23 2011-06-06 Shire Int Licensing Bv Use of lanthanum carbonate for kidney stone prevention
CA2449941A1 (en) * 2001-06-11 2002-12-19 University Of Miami Use of radiopharmaceutical complexes in achieving transplantation tolerance
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
MXPA06006801A (en) * 2003-12-17 2007-01-26 Titan Pharmaceuticals Inc Use of gallium to treat inflammatory arthritis.
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
WO2006029406A2 (en) * 2004-09-09 2006-03-16 Stryker Corporation Methods for treating bone tumors using bone morphogenic proteins
US8709380B1 (en) * 2006-02-07 2014-04-29 Sirius Medicine, Llc Targeting agents for enhancing radiation therapy
WO2008058210A2 (en) * 2006-11-09 2008-05-15 Bernstein Lawrence R Local administration of gallium compositions to treat pain
US8062364B1 (en) 2007-04-27 2011-11-22 Knee Creations, Llc Osteoarthritis treatment and device
AU2017204355B2 (en) 2016-07-08 2021-09-09 Mako Surgical Corp. Scaffold for alloprosthetic composite implant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680286A (en) * 1982-02-11 1987-07-14 Stockel Richard F Use of selenium-containing compounds for negating the toxic effects of gold compounds used in the treatment of rheumatoid arthritis, and a novel selenium-containing gold compound and use thereof as an anti-rheumatoid arthritis medicine
US4704273A (en) * 1982-05-17 1987-11-03 Mcmichael John Methods and materials for treatment of rheumatoid arthritis
US4426384A (en) * 1982-08-05 1984-01-17 John R. A. Simoons Treatment of rheumatoid arthritis and related diseases
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4906450A (en) * 1987-03-26 1990-03-06 Ephraim Lieberman Treatment of arthritis, including rheumatoid arthritis, with the radionuclide, tin SN-121
GB8907799D0 (en) * 1989-04-06 1989-05-17 Erba Carlo Spa Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases

Also Published As

Publication number Publication date
WO1998030246A1 (en) 1998-07-16
EP0952854A2 (en) 1999-11-03
US5902825A (en) 1999-05-11

Similar Documents

Publication Publication Date Title
AU5491398A (en) Composition comprising non-radioactive metal ion complexes with phosphonate compounds for the palliation of pain associated with diseases of the bone and bone joints
IL134225A0 (en) Use of locally delivered metal ions for treatment of periodontal disease
EP1049636A4 (en) Medical procedure kit
AU7601198A (en) Natural composition for treating bone or joint inflammation
EP1017379A4 (en) Therapeutic compositions
AU2212299A (en) Compositions and methods for the treatment of tumor
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
IL138129A (en) Composition for therapy of estrogen-associated disorders
PT1073416E (en) Use of inhaled no as anti-inflammatory agent
ZA9810796B (en) Skin rash prevention composition
EP0938901A4 (en) Medicinal compositions for treating liver diseases
EP0956870A4 (en) Antithrombotic medical material
EP0944635A4 (en) Diphosphonate therapeutic compounds
PL348871A1 (en) Organophosphorous compounds and the use thereof
HUP0100218A3 (en) Medical spatula
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
AU6977198A (en) Human phosphatidic acid phosphatase
AU7449698A (en) Therapeutic agents for respiratory diseases
AU697136B2 (en) Agents for treating metabolic bone diseases
AU6966998A (en) Composition for treating pain
AU7247898A (en) Composition for treating pain
ZA982395B (en) Therapeutic composition
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
EP0925791A4 (en) Preventive and/or therapeutic agent for kidney diseases